Suchergebnisse - "Uchida, Tomoyuki"

PubPharm (6)

1

Preceding bortezomib administration for a certain period reduces the risk of lenalidomide-induced skin rash

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Sugi, T. | Mita, M. | Yasu, T. | +7

2

Rapid response of secondary plasma cell leukemia after carfilzomib and dexamethasone therapy

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2022

von Fujii, T. | Ohara, S. | Uchida, T. | +3

3

Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma

enthalten in: Leukemia & lymphoma | 2021

von Sugi, T. | Nishigami, Y. | Saigo, H. | +8

4

Pomalidomide/cyclophosphamide/dexamethasone combination therapy for relapsed/refractory multiple myeloma accompanied by extramedullary lesions

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2020

von Hagihara, M. | Ide, S. | Ohara, S. | +3

5

Successful management of drug-induced skin rash in a relapsed multiple myeloma patient with pomalidomide desensitization

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2019

von Hagihara, M. | Ide, S. | Ohara, S. | +3

6

Achievement of hemodialysis discontinuation with lenalidomide and dexamethasone therapy in a refractory BJP-type multiple myeloma patient

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2016

von Uchida, T. | Inoue, M. | Hua, J. | +1

1
[1]